KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for NovoCure (NVCR) over the last 12 years, with Q3 2025 value amounting to $185.0 million.

  • NovoCure's Change in Acquisitions & Divestments fell 263.16% to $185.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $895.0 million, marking a year-over-year decrease of 127.4%. This contributed to the annual value of $778.0 million for FY2024, which is 3596.61% down from last year.
  • According to the latest figures from Q3 2025, NovoCure's Change in Acquisitions & Divestments is $185.0 million, which was down 263.16% from $420.0 million recorded in Q2 2025.
  • NovoCure's 5-year Change in Acquisitions & Divestments high stood at $608.0 million for Q1 2021, and its period low was $104.5 million during Q4 2022.
  • In the last 5 years, NovoCure's Change in Acquisitions & Divestments had a median value of $279.0 million in 2022 and averaged $285.6 million.
  • Per our database at Business Quant, NovoCure's Change in Acquisitions & Divestments plummeted by 5411.18% in 2022 and then surged by 18562.18% in 2023.
  • NovoCure's Change in Acquisitions & Divestments (Quarter) stood at $350.0 million in 2021, then plummeted by 70.14% to $104.5 million in 2022, then surged by 185.62% to $298.5 million in 2023, then crashed by 43.06% to $170.0 million in 2024, then increased by 8.82% to $185.0 million in 2025.
  • Its Change in Acquisitions & Divestments was $185.0 million in Q3 2025, compared to $420.0 million in Q2 2025 and $120.0 million in Q1 2025.